FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Georgia Chenevix-Trench

Research Profile

Disorders

Physiology

Genes & Molecular Sequences

Procedures

Co-author Network

Publications

TOP 3
Sarah Sawyer; Alison H Trainer; Geoffrey J Lindeman; Joanne McKinley; Gillian Mitchell; Jonathan Beesley; David Bowtell; Xiao Qing Chen; Georgia Chenevix-Trench; Marion Harris; Paul A James
A role for common genomic variants in the assessment of familial breast cancer.
Ana Cristina Vargas; Nic Waddell; Georgia Chenevix-Trench; Sibylle Cocciardi; Leonard da Silva; Annette Lane; Amy E McCart Reed; Lynne E Reid; Peter T Simpson; Chanel E Smart; Sarah Song; Sunil R Lakhani
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Yael Laitman; Lesley McGuffog; Katherine L Nathanson; Susan L Neuhausen; Heli Nevanlinna; Kenneth Offit; Susan Peock; Paolo Peterlongo; Paolo Radice; Johanna Rantala; Rita K Schmutzler; Olga M Sinilnikova; Barbara Wappenschmidt; Ido Wolf; Antonis C Antoniou; Adalgeir Arason; Maria Adelaide Caligo; Xiaoqing Chen; Georgia Chenevix-Trench; Fergus Couch; Douglas F Easton; Patricia Ganz; Andrew K Godwin; Sue Healey; Frans B L Hogervorst; Claudine Isaacs; Tomas Kirchhoff; Karoline B Kuchenbaecker; Eitan Friedman
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Georgia Chenevix-Trench (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sarah Sawyer; Alison H Trainer; Geoffrey J Lindeman; Joanne McKinley; Gillian Mitchell; Jonathan Beesley; David Bowtell; Xiao Qing Chen; Georgia Chenevix-Trench; Marion Harris; Paul A James
A role for common genomic variants in the assessment of familial breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4330-6.
2012: Ana Cristina Vargas; Nic Waddell; Georgia Chenevix-Trench; Sibylle Cocciardi; Leonard da Silva; Annette Lane; Amy E McCart Reed; Lynne E Reid; Peter T Simpson; Chanel E Smart; Sarah Song; Sunil R Lakhani
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Breast cancer research and treatment 2012;135(1):153-65.
2012: Yael Laitman; Lesley McGuffog; Katherine L Nathanson; Susan L Neuhausen; Heli Nevanlinna; Kenneth Offit; Susan Peock; Paolo Peterlongo; Paolo Radice; Johanna Rantala; Rita K Schmutzler; Olga M Sinilnikova; Barbara Wappenschmidt; Ido Wolf; Antonis C Antoniou; Adalgeir Arason; Maria Adelaide Caligo; Xiaoqing Chen; Georgia Chenevix-Trench; Fergus Couch; Douglas F Easton; Patricia Ganz; Andrew K Godwin; Sue Healey; Frans B L Hogervorst; Claudine Isaacs; Tomas Kirchhoff; Karoline B Kuchenbaecker; Eitan Friedman
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2012;132(3):1119-26.
2012: Julie K Johnson; Nic Waddell; Georgia Chenevix-Trench
The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.
BMC cancer 2012;12():246.
2011: Julie Johnson; Kum Kum Khanna; Sue Healey; Georgia Chenevix-Trench
Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
Breast cancer research and treatment 2011;129(1):255-63.
2011: Ellen L Goode; Kristin L White; Robert A Vierkant; Catherine M Phelan; Julie M Cunningham; Joellen M Schildkraut; Andrew Berchuck; Melissa C Larson; Brooke L Fridley; Janet E Olson; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Thomas A Sellers
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
Molecular carcinogenesis 2011;50(5):397-402.
2011: Fares Al-Ejeh; Chanel E Smart; Brian J Morrison; Georgia Chenevix-Trench; J Alejandro López; Sunil R Lakhani; Michael P Brown; Kum Kum Khanna
Breast cancer stem cells: treatment resistance and therapeutic opportunities.
Carcinogenesis 2011;32(5):650-8.
2011: Bella Kaufman; Yael Laitman; Elad Ziv; Ute Hamann; Diana Torres; Ephrat Levy Lahad; Rachel Beeri; Paul Renbaum; Anna Jakubowska; Jan Lubinski; Tomasz Huzarski; Aleksandra Tołoczko-Grabarek; Katarzyna Jaworska; Katarzyna Durda; Amanda B Sprudle; Georgia Chenevix-Trench; Jacques Simard; Douglas F Easton; Antoniou Antonis; Csilla Szabo; Eitan Friedman
The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2011;126(2):521-7.
2011: Jonathan Beesley; Sharon E Johnatty; Xiaoqing Chen; Amanda B Spurdle; Paolo Peterlongo; Monica Barile; Valeria Pensotti; Siranoush Manoukian; Paolo Radice; Georgia Chenevix-Trench
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women.
Breast cancer research and treatment 2011;126(1):235-9.
2011: Peter T Simpson; Ana-Cristina Vargas; Fares Al-Ejeh; Kum Kum Khanna; Georgia Chenevix-Trench; Sunil R Lakhani
Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
Human pathology 2011;42(2):153-65.
2011: David E Goldgar; Sue Healey; John L Hopper; Esther M John; Kum Kum Khanna; Sunil Lakhani; Peter J Oefner; Melissa C Southey; Amanda B Spurdle; Mary Beth Terry; Irene Andrulis; Saundra M Buys; Xiaoqing Chen; Leonard Da Silva; Mary J Daly; James G Dowty; Georgia Chenevix-Trench
Rare variants in the ATM gene and risk of breast cancer.
Breast cancer research : BCR 2011;13(4):R73.
2011: Catherine Emmanuel; Natalie Gava; Catherine Kennedy; Rosemary L Balleine; Raghwa Sharma; Gerard Wain; Alison Brand; Russell Hogg; Dariush Etemadmoghadam; Joshy George; Michael J Birrer; Christine L Clarke; Georgia Chenevix-Trench; David D L Bowtell; Paul R Harnett; Anna deFazio
Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.
PloS one 2011;6(3):e17617.
2011: Aimee M Near; Anna H Wu; Claire Templeman; David J Van Den Berg; Jennifer A Doherty; Mary Anne Rossing; Ellen L Goode; Julie M Cunningham; Robert A Vierkant; Brooke L Fridley; Georgia Chenevix-Trench; Penelope M Webb; Susanne Krüger Kjaer; Estrid Hogdall; Simon A Gayther; Susan J Ramus; Usha Menon; Aleksandra Gentry-Maharaj; Joellen M Schildkraut; Patricia G Moorman; Rachel T Palmieri; Roberta B Ness; Kirsten B Moysich; Daniel W Cramer; Kathryn L Terry; Allison F Vitonis; Malcolm C Pike; Andrew Berchuck; Celeste L Pearce
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.
Fertility and sterility 2011;95(1):40-5.
2010: Nic Waddell; Jeremy Arnold; Sibylle Cocciardi; Leonard da Silva; Anna Marsh; Joan Riley; Cameron N Johnstone; Mohammed Orloff; Guillaume Assie; Charis Eng; Lynne Reid; Patricia Keith; Max Yan; Stephen Fox; Peter Devilee; Andrew K Godwin; Frans B L Hogervorst; Fergus J. Couch; Sean M Grimmond; James M Flanagan; Kumkum Khanna; Peter T Simpson; Sunil R Lakhani; Georgia Chenevix-Trench
Subtypes of familial breast tumours revealed by expression and copy number profiling.
Breast cancer research and treatment 2010;123(3):661-77.
2010: Nic Waddell; Sibylle Cocciardi; Julie Johnson; Sue Healey; Anna Marsh; Joan Riley; Leonard da Silva; Ana Cristina Vargas; Lynne Reid; Peter T Simpson; Sunil R Lakhani; Georgia Chenevix-Trench
Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
The Journal of pathology 2010;221(4):452-61.
2010: Amanda B Spurdle; Paul Fahey; Xiaoqing Chen; Lesley McGuffog; Douglas Easton; Susan Peock; Margaret Cook; Jacques Simard; Tim R Rebbeck; Antonis C Antoniou; Georgia Chenevix-Trench
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2010;122(1):281-5.
2010: Antonis C Antoniou; Georgia Chenevix-Trench
Common genetic variants and cancer risk in Mendelian cancer syndromes.
Current opinion in genetics & development 2010;20(3):299-307.
2010: James M Flanagan; Sibylle Cocciardi; Nic Waddell; Cameron N Johnstone; Anna Marsh; Stephen Henderson; Peter Simpson; Leonard da Silva; Kumkum Khanna; Sunil Lakhani; Chris Boshoff; Georgia Chenevix-Trench
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
American journal of human genetics 2010;86(3):420-33.
2010: Leonard Da Silva; Peter T Simpson; Chanel E Smart; Sibylle Cocciardi; Nic Waddell; Annette Lane; Brian J Morrison; Ana Cristina Vargas; Sue Healey; Jonathan Beesley; Pria Pakkiri; Suzanne Parry; Nyoman Kurniawan; Lynne Reid; Patricia Keith; Paulo Faria; Emilio Pereira; Alena Skalova; Michael Bilous; Rosemary L Balleine; Hongdo DO; Alexander Dobrovic; Stephen Fox; Marcello Franco; Brent Reynolds; Kum Kum Khanna; Margaret Cummings; Georgia Chenevix-Trench; Sunil R Lakhani
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.
Breast cancer research : BCR 2010;12(4):R46.
2010: Sunil R Lakhani; Kum Kum Khanna; Georgia Chenevix-Trench
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
Breast cancer research : BCR 2010;12(2):104.
2010: Jeremy M Arnold; David Y H Choong; Ella R Thompson; Nic Waddell; Geoffrey J Lindeman; Jane E Visvader; Ian G Campbell; Georgia Chenevix-Trench
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.
Breast cancer research and treatment 2010;119(2):491-6.
2009: Jianjun Liu; Taru A Muranen; Heli Nevanlinna; Dianbo Qu; Melissa C Southey; Amanda B Spurdle; Karl von Smitten; Kirsimari Aaltonen; Kristiina Aittomäki; Shakeela Banu; Jonathan Beesley; Carl Blomqvist; Carine Bonnard; Hiltrud Brauch; Xiaoqing Chen; Georgia Chenevix-Trench; Kamila Czene; Kartiki Vasant Desai; Per Hall; Tuomas Heikkinen; John L Hopper; Tasneem Shabbir Kajiji; Yew Kok Lee; Yuqing Li; Edison T Liu
Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development.
The HUGO journal 2009;3(1-4):31-40.
2009: Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne LESUEUR; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine VOEGELE; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
American journal of human genetics 2009;85(4):427-46.
2009: Timothy R Rebbeck; Nandita Mitra; Susan M Domchek; Fei Wan; Shaokun Chuai; Tara Friebel; Saarene Panossian; Amanda Spurdle; Georgia Chenevix-Trench; Christian F Singer; Georg Pfeiler; Susan L Neuhausen; Henry T Lynch; Judy E Garber; Jeffrey N Weitzel; Claudine Isaacs; Fergus J. Couch; Steven A Narod; Wendy S Rubinstein; Gail Tomlinson; Patricia Anne Ganz; Olufunmilayo I Olopade; Nadine Tung; Joanne L Blum; Roger A. Greenberg; Katherine L Nathanson; Mary B Daly
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Cancer research 2009;69(14):5801-10.
2009: Sharon E Johnatty; Jonathan Beesley; Xiaoqing Chen; Amanda B Spurdle; Anna Defazio; Penelope M Webb; Ellen L Goode; David N Rider; Robert A Vierkant; Stephanie Anderson; Anna H Wu; Malcolm Pike; David Van Den Berg; Kirsten Moysich; Roberta Ness; Jennifer Doherty; Mary-Anne Rossing; Celeste Leigh Pearce; Georgia Chenevix-Trench
Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2009;12(3):269-75.
2009: Amanda B Spurdle; Andrew Deans; David Duffy; David E Goldgar; Xiaoqing Chen; Jonathan Beesley; Douglas F Easton; Antonis C Antoniou; Susan Peock; Margaret Cook; Katherine L Nathanson; Susan M Domchek; Grant A MacArthur; Georgia Chenevix-Trench
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2009;115(2):307-13.
2009: Sharon E Johnatty; Jonathan Beesley; Xiaoqing Chen; John L Hopper; Melissa C Southey; Graham G Giles; David E Goldgar; Georgia Chenevix-Trench; Amanda B Spurdle
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
Breast cancer research and treatment 2009;115(1):145-50.
2009: Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Role of genetic polymorphisms and ovarian cancer susceptibility.
Molecular oncology 2009;3(2):171-81.
2008: Michael S Anglesio; Jeremy M Arnold; joshy george; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Molecular cancer research : MCR 2008;6(11):1678-90.
2008: Sharon E Johnatty; Jonathan Beesley; James Paul; Sian Fereday; Amanda B Spurdle; Penelope M Webb; Karen Byth; Sharon Marsh; howard mcleod; Paul R Harnett; Robert Brown; Anna DeFazio; Georgia Chenevix-Trench
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5594-601.
2008: Nic Waddell; Anette Ten Haaf; Anna Marsh; Julie Johnson; Logan C Walker; Milena Gongora; Melissa Brown; Piyush Grover; Mark Girolami; Sean M Grimmond; Georgia Chenevix-Trench; Amanda B Spurdle
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression.
PLoS genetics 2008;4(5):e1000080.
2008: Sharon E Johnatty; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; John L Hopper; David L Duffy; Georgia Chenevix-Trench
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Breast cancer research and treatment 2008;109(1):91-9.
2008: Nicola Wayte; Leonard Da Silva; Georgia Chenevix-Trench; Sunil R Lakhani
What's in a cancer syndrome? Genes, phenotype and pathology.
Pathology 2008;40(3):247-59.
2008: Amanda B Spurdle; Sunil R Lakhani; Sue Healey; Suzanne Parry; Leonard M Da Silva; Ross Brinkworth; John L Hopper; Melissa A Brown; Davit Babikyan; Georgia Chenevix-Trench; Sean V Tavtigian; David E Goldgar
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1657-63.
2008: Andrew Berchuck; Joellen M Schildkraut; C Leigh Pearce; Georgia Chenevix-Trench; Paul D Pharoah
Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium.
Advances in experimental medicine and biology 2008;622():53-67.
2007: Jonathan Beesley; Susan J Jordan; Amanda B Spurdle; Honglin Song; Susan J Ramus; Suzanne Kruger Kjaer; Estrid Hogdall; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Paul D P Pharoah; Penelope M Webb; Georgia Chenevix-Trench
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(12):2557-65.
2007: Sharon E Johnatty; Christina M Nagle; Amanda B Spurdle; Xiaoqing Chen; Penelope M Webb; Georgia Chenevix-Trench
The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia).
Gynecologic oncology 2007;107(3):388-91.
2007: Anna Marsh; Sue Healey; Aaron Lewis; Amanda B Spurdle; Mary-Anne Kedda; Kum Kum Khanna; Graham J Mann; Gulietta M Pupo; Sunil R Lakhani; Georgia Chenevix-Trench
Mutation analysis of five candidate genes in familial breast cancer.
Breast cancer research and treatment 2007;105(3):377-89.
2007: Paul K Lovelock; Ee Ming Wong; Carl Sprung; Anna Marsh; Karen Hobson; Juliet D French; Melissa C Southey; Tom Sculley; Nirmala Pandeya; Melissa A Brown; Georgia Chenevix-Trench; Amanda B Spurdle; Michael McKay
Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
Breast cancer research and treatment 2007;104(3):257-66.
2007: Christina M Nagle; Georgia Chenevix-Trench; Penelope M Webb; Amanda B Spurdle
Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes.
Cancer letters 2007;251(1):96-104.
2007: Julia K Pagan; Jeremy Arnold; Kim J Hanchard; Raman Kumar; Tiziana Bruno; Mathew J K Jones; Derek Richard; Alistair Forrest; Amanda B Spurdle; Eric Verdin; Merlin Crossley; Maurizio Fanciulli; Georgia Chenevix-Trench; David B Young; Kum Kum Khanna
A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.
The Journal of biological chemistry 2007;282(20):15248-57.
2007: Amanda B Spurdle; Jiun-Horng Chang; Graham B Byrnes; Xiaoqing Chen; Gillian S Dite; Margaret R E McCredie; Graham G Giles; Melissa C Southey; Georgia Chenevix-Trench; John L Hopper
A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):769-74.
2007: Paul K Lovelock; Amanda B Spurdle; Myth T S Mok; Daniel J Farrugia; Sunil R Lakhani; Sue Healey; Stephen Arnold; Daniel Buchanan; Fergus J. Couch; Beric R Henderson; David E Goldgar; Sean V Tavtigian; Georgia Chenevix-Trench; Melissa A Brown
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Breast cancer research : BCR 2007;9(6):R82.
2007: Felicity Lose; Jeremy Arnold; David B Young; Carolyn J Brown; Graham J Mann; Gulietta M Pupo; Kum Kum Khanna; Georgia Chenevix-Trench; Amanda B Spurdle
BCoR-L1 variation and breast cancer.
Breast cancer research : BCR 2007;9(4):R54.
2007: Georgia Chenevix-Trench; Roger L Milne; Antonis C Antoniou; Fergus J. Couch; Douglas F Easton; David E Goldgar
An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).
Breast cancer research : BCR 2007;9(2):104.
2007: Christina M Nagle; Georgia Chenevix-Trench; Amanda B Spurdle; Penelope M Webb
The role of glutathione-S-transferase polymorphisms in ovarian cancer survival.
European journal of cancer (Oxford, England : 1990) 2007;43(2):283-90.
2006: Nic Waddell; Jyoti Jonnalagadda; Anna Marsh; Scott Grist; Mark Jenkins; Karen Hobson; Malcolm Taylor; Geoffrey J Lindeman; Sean V Tavtigian; Graeme Suthers; David E Goldgar; Peter J Oefner; Darrin Taylor; Sean M Grimmond; Kum Kum Khanna; Georgia Chenevix-Trench
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
Genes, chromosomes & cancer 2006;45(12):1169-81.
2006: Georgia Chenevix-Trench
What makes a good PhD student?
Nature 2006;441(7090):252.
2006: Jean S Fleming; Clare R Beaugié; Izhak Haviv; Georgia Chenevix-Trench; Olivia L Tan
Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.
Molecular and cellular endocrinology 2006;247(1-2):4-21.
2006: Jeremy M Arnold; David Y H Choong; John Lai; Ian G Campbell; Georgia Chenevix-Trench
Mutation and expression analysis of LZTS1 in ovarian cancer.
Cancer letters 2006;233(1):151-7.
2006: Georgia Chenevix-Trench; Sue Healey; Sunil Lakhani; Paul Waring; Margaret Cummings; Ross Brinkworth; Amie M Deffenbaugh; Lynn Anne Burbidge; Dmitry Pruss; Thaddeus Judkins; Thomas Scholl; Anna Bekessy; Anna Marsh; Paul K Lovelock; Ming Wong; Andrea Tesoriero; Helene Renard; Melissa C Southey; John L Hopper; Koulis Yannoukakos; Melissa Brown; Douglas Easton; Sean V Tavtigian; David E Goldgar; Amanda B Spurdle
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Cancer research 2006;66(4):2019-27.
2006: Felicity Lose; Paul K Lovelock; Georgia Chenevix-Trench; Graham J Mann; Gulietta M Pupo; Amanda B Spurdle
Variation in the RAD51 gene and familial breast cancer.
Breast cancer research : BCR 2006;8(3):R26.
2006: Graham J Mann; Heather Thorne; Rosemary L Balleine; Phyllis N Butow; Christine L Clarke; Edward Edkins; Gerda M Evans; Sián Fereday; Eric Haan; Michael Gattas; Graham G Giles; Jack Goldblatt; John L Hopper; Judy Kirk; Jennifer A Leary; Geoffrey J Lindeman; Eveline Niedermayr; Kelly-Anne Phillips; Sandra Picken; Gulietta M Pupo; Christobel Saunders; Clare L Scott; Amanda B Spurdle; Graeme Suthers; Katherine Tucker; Georgia Chenevix-Trench
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.
Breast cancer research : BCR 2006;8(1):R12.
2006: Amanda B Spurdle; Antonis C Antoniou; Livia Kelemen; Helene Holland; Susan Peock; Margaret R Cook; Paula L Smith; Mark H Greene; Jacques Simard; Marie Plourde; Melissa C Southey; Andrew K Godwin; Jeanne Beck; alexander miron; Mary B Daly; Regina M Santella; John L Hopper; Esther M John; Irene L Andrulis; Francine Durocher; Jeffery Struewing; Douglas F Easton; Georgia Chenevix-Trench
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(1):76-9.
2006: Paul K Lovelock; Sue Healey; W Au; Eleanor Y M Sum; Andrea Tesoriero; Ee Ming Wong; Shannon R Hinson; R Brinkworth; A Bekessy; O Diez; Louise Izatt; Ellen Solomon; M Jenkins; Helene Renard; J Hopper; P Waring; Sean V Tavtigian; David E Goldgar; Geoffrey J Lindeman; Jane E Visvader; Fergus J. Couch; B R Henderson; Melissa C Southey; Georgia Chenevix-Trench; Amanda B Spurdle; Melissa A Brown
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Journal of medical genetics 2006;43(1):74-83.
2005: Andrea Tesoriero; Ee Ming Wong; Mark A Jenkins; John L Hopper; Melissa A Brown; Georgia Chenevix-Trench; Amanda B Spurdle; Melissa C Southey
Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
Human mutation 2005;26(5):495.
2005: John L Hopper; Vanessa M Hayes; Amanda B Spurdle; Georgia Chenevix-Trench; Mark A Jenkins; Roger L Milne; Gillian S Dite; Andrea Tesoriero; Margaret R E McCredie; Graham G Giles; Melissa C Southey
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer.
Human mutation 2005;26(4):298-302.
2005: Anna Marsh; Carol Wicking; Brandon J Wainwright; Georgia Chenevix-Trench
DHPLC analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol-sensing domain.
Human mutation 2005;26(3):283.
2005: Bettina Kuschel; Georgia Chenevix-Trench; Amanda B Spurdle; Xiaoqing Chen; John L Hopper; Graham G Giles; Margret McCredie; Jenny Chang-Claude; Catherine S Gregory; Nicholas E Day; Douglas F Easton; Bruce A J Ponder; Alison M Dunning; Paul D P Pharoah
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(7):1828-31.
2005: JM Arnold; P R Huggard; M Cummings; G A Ramm; Georgia Chenevix-Trench
Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma.
British journal of cancer 2005;92(11):2024-31.
2005: Livia Kelemen; Michael James; Amanda B Spurdle; Ian Campbell; Jenny Chang-Claude; David Peel; Hoda Anton-Culver; Andrew Berchuck; Joellen M Schildkraut; Alice Whittemore; Valerie McGurie; Richard A DiCioccio; David Duffy; Georgia Chenevix-Trench
BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Gynecologic oncology 2005;97(3):807-12.
2005: Deborah Thompson; Antonis C Antoniou; Mark Jenkins; Anna Marsh; Xiaoqing Chen; Tierney Wayne; Andrea Tesoriero; Roger Milne; Amanda B Spurdle; Yvonne Thorstenson; Melissa C Southey; Graham G Giles; Kum Kum Khanna; Joseph Sambrook; Peter Oefner; David E Goldgar; John L Hopper; Douglas Easton; Georgia Chenevix-Trench
Two ATM variants and breast cancer risk.
Human mutation 2005;25(6):594-5.
2005: Merran Finnis; Sonia Dayan; Lynne Hobson; Georgia Chenevix-Trench; Kathryn Friend; Karin Ried; Deon J Venter; Erica Woollatt; Elizabeth Baker; Robert I Richards
Common chromosomal fragile site FRA16D mutation in cancer cells.
Human molecular genetics 2005;14(10):1341-9.
2005: C R Jekimovs; X Chen; J Arnold; Magtouf Gatei; Derek Richard; Amanda B Spurdle; Kum Kum Khanna; Georgia Chenevix-Trench
Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals.
British journal of cancer 2005;92(4):784-90.
2005: Livia Kelemen; Amanda B Spurdle; David M Purdie; Dorota M Gertig; Georgia Chenevix-Trench
RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.
Cancer letters 2005;218(2):191-7.
2005: Penelope M Webb; John L Hopper; Beth Newman; Xiaoqing Chen; Livia Kelemen; Graham G Giles; Melissa C Southey; Georgia Chenevix-Trench; Amanda B Spurdle
Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):319-23.
2005: Aaron G Lewis; James Flanagan; Anna Marsh; Gulietta M Pupo; Graham Mann; Amanda B Spurdle; Geoffrey J Lindeman; Jane E Visvader; Melissa A Brown; Georgia Chenevix-Trench
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Breast cancer research : BCR 2005;7(6):R1005-16.
2005: Christopher Pettigrew; Nicola Wayte; Paul K Lovelock; Sean V Tavtigian; Georgia Chenevix-Trench; Amanda B Spurdle; Melissa A Brown
Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
Breast cancer research : BCR 2005;7(6):R929-39.
2005: Jiun-Horng Chang; Dorota M Gertig; Xiaoqing Chen; Gillian S Dite; Mark A Jenkins; Roger L Milne; Melissa C Southey; Margaret R E McCredie; Graham G Giles; Georgia Chenevix-Trench; John L Hopper; Amanda B Spurdle
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Breast cancer research : BCR 2005;7(4):R513-21.
2005: Georgia Chenevix-Trench; Olga M Sinilnikova; Graeme Suthers; N Pandeya; Sylvie Mazoyer; Joseph Sambrook; S Goldup; David E Goldgar; H T Lynch; Gilbert M Lenoir; G Cheetham
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers.
Familial cancer 2005;4(2):73-5.
2005: Amanda B Spurdle; Antonis C Antoniou; David L Duffy; Nirmala Pandeya; Livia Kelemen; Xiaoqing Chen; Susan Peock; Margaret R Cook; Paula L Smith; David M Purdie; Beth Newman; Gillian S Dite; Carmel Apicella; Melissa C Southey; Graham G Giles; John L Hopper; Georgia Chenevix-Trench; Douglas F Easton
The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research : BCR 2005;7(2):R176-83.
2004: Andrew Berchuck; Joellen M Schildkraut; Robert M Wenham; Brian Calingaert; Shazia Ali; Amy Henriott; Susan Halabi; Gustavo Rodriguez; Dorota M Gertig; David M Purdie; Livia Kelemen; Amanda B Spurdle; Jeffrey Marks; Georgia Chenevix-Trench
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(12):2141-7.
2004: Kum Kum Khanna; Georgia Chenevix-Trench
ATM and genome maintenance: defining its role in breast cancer susceptibility.
Journal of mammary gland biology and neoplasia 2004;9(3):247-62.
2004: James M Flanagan; Sue Healey; Joanne Young; Vicki Whitehall; Deborah A Trott; Robert F Newbold; Georgia Chenevix-Trench
Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Genes, chromosomes & cancer 2004;40(3):247-60.
2004: Patricia A Mote; Jennifer A Leary; Kelly A Avery; Kerstin Sandelin; Georgia Chenevix-Trench; Judy A Kirk; Christine L Clarke
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Genes, chromosomes & cancer 2004;39(3):236-48.
2004: Ian G Campbell; David Y H Choong; Georgia Chenevix-Trench
No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.
Breast cancer research : BCR 2004;6(4):R366-71.
2003: James Flanagan; Sue Healey; Joanne Young; Vicki Whitehall; Georgia Chenevix-Trench
Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer.
International journal of cancer. Journal international du cancer 2003;106(4):505-9.
2003: Amanda B Spurdle; David M Purdie; Xiaoqing Chen; Georgia Chenevix-Trench
The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer.
Gynecologic oncology 2003;90(1):145-9.
2003: Peter Wilson; Andrew Cuthbert; Anna Marsh; Jeremy Arnold; James Flanagan; Christine Mulford; Deborah Trott; Elizabeth Baker; David Purdie; Robert Newbold; Georgia Chenevix-Trench
Transfer of chromosome 8 into two breast cancer cell lines: total exclusion of three regions indicates location of putative in vitro growth suppressor genes.
Cancer genetics and cytogenetics 2003;143(2):100-12.
2003: Jisheng Cui; Amanda B Spurdle; Melissa C Southey; Gillian S Dite; Deon J Venter; Margaret R E McCredie; Graham G Giles; Georgia Chenevix-Trench; John L Hopper
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.
Genetic epidemiology 2003;24(3):161-72.
2003: J Lai; James Flanagan; W A Phillips; Georgia Chenevix-Trench; J Arnold
Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
British journal of cancer 2003;88(2):270-6.
2003: Annika Auranen; Amanda B Spurdle; Xiaoqing Chen; Julian M Lipscombe; David M Purdie; John L Hopper; Adele Green; Catherine S Healey; Karen Redman; Alison M Dunning; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; Georgia Chenevix-Trench; Karen L Novik
BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk.
International journal of cancer. Journal international du cancer 2003;103(3):427-30.
2002: Jeremy M Arnold; Erica Woollatt; Georgia Chenevix-Trench
Chromosome 8 genetic analysis and phenotypic characterization of 21 ovarian cancer cell lines.
Cancer genetics and cytogenetics 2002;139(2):109-14.
2002: Amanda B Spurdle; John L Hopper; Xiaoqing Chen; Margaret R E McCredie; Graham G Giles; Beth Newman; Georgia Chenevix-Trench
Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women.
Lancet 2002;360(9337):925-6.
2002: Amanda B Spurdle; Bryan Goodwin; Ecushla Hodgson; John L Hopper; Xiaoqing Chen; David M Purdie; Margaret R E McCredie; Graham G Giles; Georgia Chenevix-Trench; Christopher Liddle
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.
Pharmacogenetics 2002;12(5):355-66.
2002: Amanda B Spurdle; John L Hopper; Xiaoqing Chen; Margaret R E McCredie; Graham G Giles; Deon J Venter; Melissa C Southey; Georgia Chenevix-Trench
The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(5):439-43.
2002: Amanda B Spurdle; John L Hopper; Xiaoqing Chen; Gillian S Dite; Jisheng Cui; Margaret R E McCredie; Graham G Giles; Sarah Ellis-Steinborner; Deon J Venter; Beth Newman; Melissa C Southey; Georgia Chenevix-Trench
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):413-6.
2002: Georgia Chenevix-Trench; Amanda B Spurdle; Magtouf Gatei; Helena Kelly; Anna Marsh; Xiaoqing Chen; Karen Donn; Margaret Cummings; Dale R Nyholt; Mark A Jenkins; Clare Scott; Gulietta M Pupo; Thilo Dörk; Regina Bendix; Judy Kirk; Katherine Tucker; Margaret R E McCredie; John L Hopper; Joseph Sambrook; Graham J Mann; Kum Kum Khanna
Dominant negative ATM mutations in breast cancer families.
Journal of the National Cancer Institute 2002;94(3):205-15.
2002: Amanda B Spurdle; John L Hopper; Xiaoqing Chen; Margaret R E McCredie; Graham G Giles; Beth Newman; Georgia Chenevix-Trench; KumKum Khanna
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer.
Breast cancer research : BCR 2002;4(6):R15.
2001: Amanda B Spurdle; John L Hopper; Xiaoqing Chen; Gillian S Dite; Margaret R E McCredie; Graham G Giles; Deon J Venter; Melissa C Southey; David M Purdie; Georgia Chenevix-Trench
The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(12):1287-93.
2001: JM Arnold; M Cummings; D Purdie; Georgia Chenevix-Trench
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
British journal of cancer 2001;85(9):1351-8.
2001: W W Wang; Amanda B Spurdle; Prema Kolachana; Betsy Bove; Baruch Modan; Sarah Ebbers; Graeme Suthers; Margaret A Tucker; David J Kaufman; Michele Morin Doody; Robert E Tarone; Mary Daly; Hanoch Levavi; Heather Hanson Pierce; Angela Chetrit; G H Yechezkel; Georgia Chenevix-Trench; Kenneth Offit; Andrew K Godwin; Jeffery Struewing
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(9):955-60.
2001: JM Arnold; S C Mok; D Purdie; Georgia Chenevix-Trench
Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
British journal of cancer 2001;84(3):352-9.
2001: Anna Marsh; Amanda B Spurdle; B C Turner; S Fereday; Heather Thorne; Gulietta M Pupo; Graham J Mann; John L Hopper; Joseph Sambrook; Georgia Chenevix-Trench
The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia.
Breast cancer research : BCR 2001;3(5):346-9.
2001: Amanda B Spurdle; D M Purdie; Penelope M Webb; Xiaoqing Chen; A Green; Georgia Chenevix-Trench
The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.
Molecular carcinogenesis 2001;30(1):71-8.
2001: Amanda B Spurdle; Penelope M Webb; D M Purdie; Xiaoqing Chen; A Green; Georgia Chenevix-Trench
Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.
Carcinogenesis 2001;22(1):67-72.
2000: Amanda B Spurdle; John L Hopper; Gillian S Dite; Xiaoqing Chen; Jisheng Cui; Margaret R E McCredie; Graham G Giles; Melissa C Southey; Deon J Venter; D F Easton; Georgia Chenevix-Trench
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Journal of the National Cancer Institute 2000;92(20):1674-81.
2000: Amanda B Spurdle; Penelope M Webb; Xiaoqing Chen; Nicholas G Martin; Graham G Giles; John L Hopper; Georgia Chenevix-Trench
Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.
International journal of cancer. Journal international du cancer 2000;87(5):637-43.
2000: W Boonchai; M Walsh; M Cummings; Georgia Chenevix-Trench
Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma.
Archives of dermatology 2000;136(7):937-8.
2000: R H Osborne; John L Hopper; Judy A Kirk; Georgia Chenevix-Trench; Heather Thorne; Joseph Sambrook
kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
The Medical journal of Australia 2000;172(9):463-4.
2000: Amanda B Spurdle; Xiaoqing Chen; M Abbazadegan; N Martin; Soo-Keat Khoo; TG Hurst; B Ward; Penelope M Webb; Georgia Chenevix-Trench
CYP17 promotor polymorphism and ovarian cancer risk.
International journal of cancer. Journal international du cancer 2000;86(3):436-9.
2000: W Boonchai; M Walsh; M Cummings; Georgia Chenevix-Trench
Expression of p53 in arsenic-related and sporadic basal cell carcinoma.
Archives of dermatology 2000;136(2):195-8.
2000: Tina Bianco; Georgia Chenevix-Trench; D C Walsh; J E Cooper; Alexander Dobrovic
Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
Carcinogenesis 2000;21(2):147-51.
2000: T Evans; W Boonchai; S Shanley; Ian Smyth; S Gillies; Kylie Georgas; Brandon J Wainwright; Georgia Chenevix-Trench; Carol Wicking
The spectrum of patched mutations in a collection of Australian basal cell carcinomas.
Human mutation 2000;16(1):43-8.
2000: P J Wilson; Edwina McGlinn; Anna Marsh; T Evans; J Arnold; K Wright; Kelli G Biden; Joanne Young; Brandon J Wainwright; Carol Wicking; Georgia Chenevix-Trench
Sequence variants of DLC1 in colorectal and ovarian tumours.
Human mutation 2000;15(2):156-65.
1999: K Wright; P Wilson; SJ Morland; I Campbell; M Walsh; TG Hurst; B Ward; M Cummings; Georgia Chenevix-Trench
beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours.
International journal of cancer. Journal international du cancer 1999;82(5):625-9.
1999: Amanda B Spurdle; Gillian S Dite; Xiaoqing Chen; C J Mayne; Melissa C Southey; LE Batten; H Chy; L Trute; Margaret R E McCredie; Graham G Giles; Jane E Armes; Deon J Venter; John L Hopper; Georgia Chenevix-Trench
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.
Journal of the National Cancer Institute 1999;91(11):961-6.
1999: Ian Smyth; Monica Narang; T Evans; C Heimann; Y Nakamura; Georgia Chenevix-Trench; T Pietsch; Carol Wicking; Brandon J Wainwright
Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32.
Human molecular genetics 1999;8(2):291-7.
1999: Kylie Georgas; Letitia Burridge; K Smith; GP Holmes; Georgia Chenevix-Trench; P A Ioannou; Melissa H Little
Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2.
Cytogenetics and cell genetics 1999;86(3-4):246-7.
1998: Penelope M Webb; A Green; Margaret C Cummings; David M Purdie; Michael D Walsh; Georgia Chenevix-Trench
Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
Journal of the National Cancer Institute 1998;90(22):1729-34.
1998: K Wright; P J Wilson; J Kerr; K Do; TG Hurst; Soo-Keat Khoo; B Ward; Georgia Chenevix-Trench
Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
Oncogene 1998;17(9):1185-8.
1998: Carol Wicking; Lisa A Simms; T Evans; M Walsh; Kallayanee Chawengsaksophak; F Beck; Georgia Chenevix-Trench; Joanne Young; Jeremy Jass; Barbara A Leggett; Brandon J Wainwright
CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer.
Oncogene 1998;17(5):657-9.
1998: YC Shih; J Kerr; TG Hurst; Soo-Keat Khoo; B G Ward; Georgia Chenevix-Trench
No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms.
Gynecologic oncology 1998;69(3):210-3.
1998: K Obata; SJ Morland; RH Watson; A Hitchcock; Georgia Chenevix-Trench; EJ Thomas; IG Campbell
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Cancer research 1998;58(10):2095-7.
1998: Ian Smyth; Carol Wicking; Brandon J Wainwright; Georgia Chenevix-Trench
The effects of splice site mutations in patients with naevoid basal cell carcinoma syndrome.
Human genetics 1998;102(5):598-601.
1998: Carol Wicking; T Evans; B Henk; N Hayward; Lisa A Simms; Georgia Chenevix-Trench; T Pietsch; Brandon J Wainwright
No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types.
Oncogene 1998;16(8):1091-3.
1997: Carol Wicking; S Gillies; Ian Smyth; S Shanley; Lindsay F Fowles; J Ratcliffe; Brandon J Wainwright; Georgia Chenevix-Trench
De novo mutations of the Patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype.
American journal of medical genetics 1997;73(3):304-7.
1997: Georgia Chenevix-Trench; T Coombs; J Kerr; David Purdie; A Green; Margaret C Cummings
Fertility and incidence of KRAS2 mutations in borderline ovarian adenocarcinomas.
Journal of the National Cancer Institute 1997;89(12):890-1.
1997: YC Shih; J Kerr; J Liu; TG Hurst; Soo-Keat Khoo; B Ward; B Wainwright; Georgia Chenevix-Trench
Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours.
International journal of cancer. Journal international du cancer 1997;70(5):508-11.
1997: Georgia Chenevix-Trench; J Kerr; TG Hurst; YC Shih; David Purdie; L Bergman; M Friedlander; B Sanderson; Anna Zournazi; T Coombs; J A Leary; E Crawford; Andrew N Shelling; I Cooke; Trivadi Ganesan; J Searle; C Choi; J C Barrett; Soo-Keat Khoo; B Ward
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations.
Genes, chromosomes & cancer 1997;18(2):75-83.
1997: Carol Wicking; S Shanley; Ian Smyth; S Gillies; K Negus; S Graham; G Suthers; N Haites; M Edwards; Brandon J Wainwright; Georgia Chenevix-Trench
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident.
American journal of human genetics 1997;60(1):21-6.
1996: C E Gustafson; P J Wilson; R Lukeis; E Baker; E Woollatt; L Annab; L Hawke; J C Barrett; Georgia Chenevix-Trench
Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer.
Cancer research 1996;56(22):5238-45.
1996: J Kerr; J A Leary; TG Hurst; Y C Shih; Toni M Antalis; M Friedlander; E Crawford; Soo-Keat Khoo; B Ward; Georgia Chenevix-Trench
Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus.
Oncogene 1996;13(8):1815-8.
1996: H Hahn; Carol Wicking; P G Zaphiropoulous; MR Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; Ian Smyth; C Pressman; David J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; Georgia Chenevix-Trench; Brandon J Wainwright; Allen E Bale
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.
Cell 1996;85(6):841-51.
1995: L E Mitchell; S C Healey; Georgia Chenevix-Trench
Evidence for an association between nonsyndromic cleft lip with or without cleft palate and a gene located on the long arm of chromosome 4.
American journal of human genetics 1995;57(5):1130-6.
1995: S M Shanley; Georgia Chenevix-Trench; J Palmer; N Hayward
Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.
Carcinogenesis 1995;16(8):2003-4.
1995: Georgia Chenevix-Trench; J Young; Marjorie Coggan; P Board
Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset.
Carcinogenesis 1995;16(7):1655-7.
1995: J A Leary; J Kerr; Georgia Chenevix-Trench; C P Doris; TG Hurst; C R Houghton; M L Friedlander
Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 1995;64(3):189-95.
1995: J F Ratcliffe; S Shanley; Georgia Chenevix-Trench
The prevalence of cervical and thoracic congenital skeletal abnormalities in basal cell naevus syndrome; a review of cervical and chest radiographs in 80 patients with BCNS.
The British journal of radiology 1995;68(810):596-9.
1995: Barbara A Leggett; Joanne Young; Ron Buttenshaw; L Thomas; B Young; Georgia Chenevix-Trench; J Searle; M Ward
Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region.
British journal of cancer 1995;71(5):1070-3.
1995: J F Ratcliffe; S Shanley; J Ferguson; Georgia Chenevix-Trench
The diagnostic implication of falcine calcification on plain skull radiographs of patients with basal cell naevus syndrome and the incidence of falcine calcification in their relatives and two control groups.
The British journal of radiology 1995;68(808):361-8.
1995: Joanne Young; J Searle; Ron Buttenshaw; L Thomas; M Ward; Georgia Chenevix-Trench; Barbara A Leggett
An Alu VpA marker on chromosome I demonstrates that replication errors manifest at the adenoma-carcinoma transition in sporadic colorectal tumors.
Genes, chromosomes & cancer 1995;12(4):251-4.
1995: Carol Wicking; M Breen; K Negus; J Berkman; A Evdokiou; Prudence A Cowled; Georgia Chenevix-Trench; Brandon J Wainwright
The human growth-arrest-specific gene GAS1 maps outside the candidate region of the gene for nevoid basal cell carcinoma syndrome.
Cytogenetics and cell genetics 1995;68(1-2):119-21.
1995: S M Shanley; H Dawkins; Brandon J Wainwright; Carol Wicking; P Heenan; M Eldon; J Searle; Georgia Chenevix-Trench
Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas.
Human molecular genetics 1995;4(1):129-33.
1994: C E Gustafson; J Young; Barbara A Leggett; J Searle; Georgia Chenevix-Trench
Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
British journal of cancer 1994;70(3):395-7.
1994: Carol Wicking; J Berkman; Brandon J Wainwright; Georgia Chenevix-Trench
Fine genetic mapping of the gene for nevoid basal cell carcinoma syndrome.
Genomics 1994;22(3):505-11.
1994: Georgia Chenevix-Trench; J Kerr; M Friedlander; TG Hurst; B Sanderson; M Coglan; B Ward; J Leary; Soo-Keat Khoo
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.
American journal of human genetics 1994;55(1):143-9.
1994: S Healey; F Powell; M Battersby; Georgia Chenevix-Trench; J McGill
Distinct phenotype in maternal uniparental disomy of chromosome 14.
American journal of medical genetics 1994;51(2):147-9.
1994: S Shanley; J Ratcliffe; A Hockey; E Haan; C Oley; David Ravine; N Martin; Carol Wicking; Georgia Chenevix-Trench
Nevoid basal cell carcinoma syndrome: review of 118 affected individuals.
American journal of medical genetics 1994;50(3):282-90.
1994: Joanne Young; Ron Buttenshaw; L Butterworth; M Ward; J Searle; Barbara A Leggett; Georgia Chenevix-Trench
Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Oncogene 1994;9(4):1053-6.
1994: J Berkman; J A Armour; Georgia Chenevix-Trench; Carol Wicking; Brandon J Wainwright
Simple repeat polymorphism at the D9S151 locus.
Human molecular genetics 1994;3(1):211.
1993: Barbara A Leggett; L R Thomas; N Knight; S Healey; Georgia Chenevix-Trench; J Searle
Exclusion of APC and MCC as the gene defect in one family with familial juvenile polyposis.
Gastroenterology 1993;105(5):1313-6.
1993: Georgia Chenevix-Trench; Carol Wicking; J Berkman; H Sharpe; A Hockey; E Haan; C Oley; David Ravine; A Turner; D Goldgar
Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity.
American journal of human genetics 1993;53(3):760-7.
1993: Joanne Young; Barbara A Leggett; M Ward; L Thomas; Ron Buttenshaw; J Searle; Georgia Chenevix-Trench
Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.
Oncogene 1993;8(3):671-5.
1993: Georgia Chenevix-Trench; S Healey; N G Martin
Reproductive hormone genes in mothers of spontaneous dizygotic twins: an association study.
Human genetics 1993;91(2):118-20.
1993: Joanne Young; Barbara A Leggett; C Gustafson; M Ward; J Searle; L Thomas; Ron Buttenshaw; Georgia Chenevix-Trench
Genomic instability occurs in colorectal carcinomas but not in adenomas.
Human mutation 1993;2(5):351-4.
1993: J A Reeder; JL Dickinson; Georgia Chenevix-Trench; Toni M Antalis
Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell.
Teratogenesis, carcinogenesis, and mutagenesis 1993;13(2):75-88.
1992: Georgia Chenevix-Trench; K Jones; Adèle C Green; D L Duffy; N G Martin
Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci.
American journal of human genetics 1992;51(6):1377-85.
1992: Georgia Chenevix-Trench; M Cullinan; Kay A O Ellem; Nicholas K Hayward
UV induction of transforming growth factor alpha in melanoma cell lines is a posttranslational event.
Journal of cellular physiology 1992;152(2):328-36.
1992: C A Oley; H Sharpe; Georgia Chenevix-Trench
Basal cell carcinomas, coarse sparse hair, and milia.
American journal of medical genetics 1992;43(5):799-804.
1992: Georgia Chenevix-Trench; J Leary; J Kerr; J Michel; Richard F Kefford; TG Hurst; Peter G Parsons; M Friedlander; Soo-Keat Khoo
Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
Oncogene 1992;7(6):1059-65.
1991: S C Healey; M Southall; N G Martin; Georgia Chenevix-Trench
MspI RFLP of FSHB on chromosome 11p.
Nucleic acids research 1991;19(24):6981.
1991: S C Healey; N G Martin; Georgia Chenevix-Trench
NcoI RFLP of the human LHRH gene on chromosome 8p.
Nucleic acids research 1991;19(21):6059.
1991: N G Martin; D M Robertson; Georgia Chenevix-Trench; D M de Kretser; J Osborne; H G Burger
Elevation of follicular phase inhibin and luteinizing hormone levels in mothers of dizygotic twins suggests nonovarian control of human multiple ovulation.
Fertility and sterility 1991;56(3):469-74.
1991: J Helen Leonard; John H Kearsley; Georgia Chenevix-Trench; Nicholas K Hayward
Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
International journal of cancer. Journal international du cancer 1991;48(4):511-5.
1990: Georgia Chenevix-Trench; M Southall; S Healey; A Stewart; R Forage; N G Martin
BamHI RFLP of the inhibin beta B (INHBB) chain gene on chromosome 2.
Nucleic acids research 1990;18(24):7469.
1990: Joanne Young; Toni M Antalis; Georgia Chenevix-Trench
BcII RFLP of the plasminogen activator inhibitor type 2 gene (PLANH) on chromosome 18q21-q23.
Nucleic acids research 1990;18(23):7196.
1990: M Southall; Georgia Chenevix-Trench
PstI RFLP of the CGB gene.
Nucleic acids research 1990;18(18):5579.
1990: Georgia Chenevix-Trench; N G Martin; Kay A O Ellem
Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
Oncogene 1990;5(8):1187-93.
1989: Georgia Chenevix-Trench; M Southall; C Kidson
Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
British journal of cancer 1989;60(6):872-4.
1989: Georgia Chenevix-Trench; M Southall; C Kidson
The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
International journal of cancer. Journal international du cancer 1989;43(6):1034-6.